Bristol-Myers Squibb Co. (BMY)

Bristol-Myers Squibb Co., net profit margin, long-term trends, calculation

	Net Profit Margin	=	100	×	Net earnings attributable to BMS1	÷	Revenues1
Dec 31, 2005		=	100	×		÷
Dec 31, 2006		=	100	×		÷
Dec 31, 2007		=	100	×		÷
Dec 31, 2008		=	100	×		÷
Dec 31, 2009		=	100	×		÷
Dec 31, 2010		=	100	×		÷
Dec 31, 2011		=	100	×		÷
Dec 31, 2012		=	100	×		÷
Dec 31, 2013		=	100	×		÷
Dec 31, 2014		=	100	×		÷
Dec 31, 2015		=	100	×		÷
Dec 31, 2016		=	100	×		÷
Dec 31, 2017		=	100	×		÷
Dec 31, 2018		=	100	×		÷

Based on: 10-K (filing date: 2006-03-14), 10-K (filing date: 2007-02-26), 10-K (filing date: 2008-02-22), 10-K (filing date: 2009-02-20), 10-K (filing date: 2010-02-19), 10-K (filing date: 2011-02-18), 10-K (filing date: 2012-02-17), 10-K (filing date: 2013-02-15), 10-K (filing date: 2014-02-14), 10-K (filing date: 2015-02-13), 10-K (filing date: 2016-02-12), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-13), 10-K (filing date: 2019-02-25).

¹ USD $ in millions

Bristol-Myers Squibb Co., net profit margin, long-term trends, comparison to competitors

	Bristol-Myers Squibb Co.	Abbott Laboratories	AbbVie Inc.	Allergan PLC	Amgen Inc.	Biogen Inc.	Celgene Corp.	Eli Lilly & Co.	Gilead Sciences Inc.	Johnson & Johnson	Merck & Co. Inc.	Pfizer Inc.	Regeneron Pharmaceuticals Inc.
Dec 31, 2005
Dec 31, 2006
Dec 31, 2007
Dec 31, 2008
Dec 31, 2009
Dec 31, 2010
Dec 31, 2011
Dec 31, 2012
Dec 31, 2013
Dec 31, 2014
Dec 31, 2015
Dec 31, 2016
Dec 31, 2017
Dec 31, 2018

Based on: 10-K (filing date: 2006-03-14), 10-K (filing date: 2007-02-26), 10-K (filing date: 2008-02-22), 10-K (filing date: 2009-02-20), 10-K (filing date: 2010-02-19), 10-K (filing date: 2011-02-18), 10-K (filing date: 2012-02-17), 10-K (filing date: 2013-02-15), 10-K (filing date: 2014-02-14), 10-K (filing date: 2015-02-13), 10-K (filing date: 2016-02-12), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-13), 10-K (filing date: 2019-02-25).

Bristol-Myers Squibb Co., net profit margin, long-term trends, comparison to Pharmaceuticals & Biotechnology sector

	Bristol-Myers Squibb Co.	Pharmaceuticals & Biotechnology
Dec 31, 2005
Dec 31, 2006
Dec 31, 2007
Dec 31, 2008
Dec 31, 2009
Dec 31, 2010
Dec 31, 2011
Dec 31, 2012
Dec 31, 2013
Dec 31, 2014
Dec 31, 2015
Dec 31, 2016
Dec 31, 2017
Dec 31, 2018

Based on: 10-K (filing date: 2006-03-14), 10-K (filing date: 2007-02-26), 10-K (filing date: 2008-02-22), 10-K (filing date: 2009-02-20), 10-K (filing date: 2010-02-19), 10-K (filing date: 2011-02-18), 10-K (filing date: 2012-02-17), 10-K (filing date: 2013-02-15), 10-K (filing date: 2014-02-14), 10-K (filing date: 2015-02-13), 10-K (filing date: 2016-02-12), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-13), 10-K (filing date: 2019-02-25).

Bristol-Myers Squibb Co., net profit margin, long-term trends, comparison to Health Care industry

	Bristol-Myers Squibb Co.	Health Care
Dec 31, 2005
Dec 31, 2006
Dec 31, 2007
Dec 31, 2008
Dec 31, 2009
Dec 31, 2010
Dec 31, 2011
Dec 31, 2012
Dec 31, 2013
Dec 31, 2014
Dec 31, 2015
Dec 31, 2016
Dec 31, 2017
Dec 31, 2018

Based on: 10-K (filing date: 2006-03-14), 10-K (filing date: 2007-02-26), 10-K (filing date: 2008-02-22), 10-K (filing date: 2009-02-20), 10-K (filing date: 2010-02-19), 10-K (filing date: 2011-02-18), 10-K (filing date: 2012-02-17), 10-K (filing date: 2013-02-15), 10-K (filing date: 2014-02-14), 10-K (filing date: 2015-02-13), 10-K (filing date: 2016-02-12), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-13), 10-K (filing date: 2019-02-25).